Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Sales | 3,081 | 3,152 | 3,171 | 3,891 | 3,303 |
| Cost of Goods | 1,503 | 2,255 | 1,847 | 1,947 | 2,375 |
| Gross Profit | 1,578 | 897 | 1,324 | 1,944 | 928 |
| Operating Expenses | 4,779 | 3,672 | 3,710 | 6,209 | 4,397 |
| Operating Income | -2,699 | -2,520 | -1,540 | -3,318 | -3,094 |
| Interest Expense | 192 | 178 | 139 | 143 | 60 |
| Other Income | 7,905 | -11,038 | -1,067 | -1,200 | -48 |
| Pre-tax Income | 5,014 | -13,736 | -2,746 | -4,661 | -3,202 |
| Net Income Continuous | 5,014 | -13,736 | -2,746 | -4,661 | -3,202 |
| Minority Interests | 12 | 6 | 1 | 20 | -42 |
| Net Income | $5,002 | $-13,742 | $-2,746 | $-4,680 | $-3,161 |
| EPS Basic Total Ops | 0.29 | -0.74 | -0.16 | -0.28 | 0.55 |
| EPS Basic Continuous Ops | 0.27 | -0.74 | -0.16 | -0.28 | 0.55 |
| EPS Diluted Total Ops | 0.29 | -0.74 | -0.16 | -0.28 | 0.55 |
| EPS Diluted Continuous Ops | 0.27 | -0.74 | -0.16 | -0.28 | 0.55 |
| EPS Diluted Before Non-Recurring Items | 0.31 | -0.74 | -0.16 | -0.28 | N/A |
| EBITDA(a) | $-655 | $941 | $143 | $-1,669 | $-2,139 |